Replies to post #576162 on NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Capt.

In reality NWBO doesn't have any control over events like the MIA. The only actual control they have over approval of the FlaskWorks unit is in furthering it's development to the point that they are convinced that it's ready to undergo whatever testing the regulators will put it under. I would expect that they'll be able to discuss how it's to be tried by the regulators before the trial begins, but then it's out of the company's hands.

Much the same is true of any submission they make to the regulators, once something is turned over to them, the ball is totally in their court.

What the company does have some control over is what they say. Just today the I-Hub site had a link to an invitation for them to speak at the Emerging Growth Conference, I have seen similar links before, NWBO previously hasn't chosen to make a presentation. If they're not in a quiet period, which I don't believe they are now, there are a variety of Brokerage and Institutional Conferences the company could be invited to, in some cases they'd have to pay to make an appearance, but I cannot remember the last time they did such a presentation. Both the SEC and FDA abhor hype, any presentation they make should clearly just be presenting the facts, but that ought to be a pretty positive without any hype. Now that the Journal is out the company can certainly speak about what's in it. They can speak about any information they put into the Annual or Quarterly report. My point is that they have things they could say, but they need to get on the agendas of these various conferences to say them.

I believe the company has a strategy that appears to be based on keeping the spotlight off themselves, at least for now. Certainly Drs. Liau, Ashkan, etc. have been speaking out freely in the scientific community, but not in the investment community. I believe the day will come when the company will want to put themselves in the spotlight, I just can't say when that day will be. Clearly Dr. Bosch is making a presentation shortly, but again it's more technical than investors. When we get a PR saying that in the coming month we'll be speaking at the following conferences, and webcasts will be available, and achieved on the corporate website, we'll know they're coming out. Until that time, for all we know they're spending every waking hour working on gaining regulatory approval, but frankly I'd like to see them coming out in the same way that other companies do.

Gary